Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
St. Jude Children's Research Hospital
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Medical College of Wisconsin
Oncternal Therapeutics, Inc
Ann & Robert H Lurie Children's Hospital of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Hutchmed
University of Virginia
Stanford University
Bayer
Gradalis, Inc.
Bristol-Myers Squibb
Gradalis, Inc.
Eisai Inc.
Eisai Inc.
PharmaMar
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Celgene
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
University of Oxford
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
Children's Oncology Group
Merck Sharp & Dohme LLC
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
National Institutes of Health Clinical Center (CC)
University of South Florida
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company